by Jessica Casebolt | Sep 11, 2023 | Life Sciences, Tea Leaves
CVS Health said on Wednesday that it has launched a new company called Cordavis that will work directly with manufacturers to commercialize and co-produce biosimilar medicines for the U.S. market. CVS will initially work with the manufacturer Sandoz to produce a...
by Jessica Casebolt | Sep 11, 2023 | Providers, Tea Leaves
High labor costs, rising interest rates, and looming federal staffing minimums are prompting more nursing homes and senior living operators to file for bankruptcy. According to Gibbins Advisors, a health care advisory and restructuring consultancy, the two kinds of...
by Jessica Casebolt | Sep 11, 2023 | Payers, Tea Leaves
The Biden administration is expected to disclose early next week the first 10 prescription drugs selected for Medicare price negotiations, ahead of a White House event Tuesday to celebrate the milestone. The announcement will mark a major step in a bid to lower drug...
by Jessica Casebolt | Sep 11, 2023 | Life Sciences, Tea Leaves
According to research published Wednesday, gender-affirming surgeries dipped in 2020 after nearly tripling in the years leading up to the pandemic. The study, published in JAMA Network Open, found that the number of gender-affirming procedures performed in the U.S....
by Jessica Casebolt | Sep 11, 2023 | Inequities and SDOH, Tea Leaves
Health systems are screening more patients for social determinants of health, but distrustful patients and a lack of resources hinder progress. Patients may feel shame or worry about the potential consequences of revealing that their living situations are precarious...
Recent Comments